HKD 0.34
(-6.94%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 37.3 Million CNY | -13.98% |
2022 | 41.62 Million CNY | -7.06% |
2021 | 44.78 Million CNY | -3.76% |
2020 | 46.53 Million CNY | 36.93% |
2019 | 33.98 Million CNY | 266.24% |
2018 | 9.28 Million CNY | 4.06% |
2017 | 8.91 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q2 | 20.17 Million HKD | 0.0% |
2023 FY | 35.8 Million CNY | -13.98% |
2023 Q4 | 18.93 Million HKD | 0.0% |
2022 FY | 41.62 Million CNY | -7.06% |
2022 Q4 | 25.01 Million HKD | 0.0% |
2022 Q2 | 22.72 Million HKD | 0.0% |
2021 Q2 | 21.9 Million HKD | 0.0% |
2021 FY | 44.78 Million CNY | -3.76% |
2021 Q4 | 31.43 Million HKD | 0.0% |
2020 Q4 | 21.15 Million CNY | 136.92% |
2020 Q3 | 8.92 Million CNY | 0.0% |
2020 FY | 46.53 Million CNY | 36.93% |
2019 Q4 | 10.06 Million CNY | 0.0% |
2019 FY | 33.98 Million CNY | 266.24% |
2018 FY | 9.28 Million CNY | 4.06% |
2017 FY | 8.91 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
CSPC Pharmaceutical Group Limited | 16.71 Billion HKD | 99.777% |